The Use of Ultrasound Detection of Lipohypertrophy to Improve Glycemic Control
This study titled 'The Use of Ultrasound Detection of Lipohypertrophy to Improve Glycemic Control' is for people with diabetes. When you inject insulin, sometimes fatty lumps called lipohypertrophy can form under the skin. Previous research suggests injecting into these lumps can make insulin less effective and mean you need more of it. This study will use ultrasound to find these areas, even very small ones that can't be felt, and see if avoiding them when injecting insulin helps people control their blood sugar better. The study has two phases: the first phase uses ultrasound to find these fatty areas, and the second phase looks at how injecting into or away from these areas affects blood sugar levels. It aims to help people with diabetes improve their health by understanding better how to inject insulin.
At a glance
What is this study about?
When you have diabetes and inject insulin, you might sometimes notice firm, lumpy, or bumpy areas under your skin where you usually inject. These are called 'lipohypertrophy' (say: lip-oh-high-per-tro-fee) and they are essentially swollen fatty tissues. Many years of injecting insulin in the same spots can cause these areas to develop. Previous studies have shown that injecting insulin into these lumpy areas can make it harder for your body to absorb the insulin properly, which means your blood sugar levels might not be as well controlled, and you might even need more insulin to get the same effect.
Now, new technology called ultrasound can help us see these fatty lumps, even ones that are too small to feel with your fingers. We call these 'subclinical lipohypertrophy'. This study wants to find out if these smaller, hidden lumps also affect how insulin works and, most importantly, if avoiding both the noticeable and hidden lumps when you inject insulin can help you manage your blood sugar levels more effectively.
The study has two main parts. In the first part, we will use ultrasound scans to find these areas of lipohypertrophy in 100 volunteers. In the second part, 40 of these volunteers who have the hidden type of lipohypertrophy will take part in a special experiment. They will be asked to carefully check their blood sugar levels while injecting insulin into areas with and without these lumps to see if there's a difference. The goal is to learn how best to inject insulin to achieve better blood sugar control for people living with diabetes.
Key takeaways
- This study investigates if avoiding fatty lumps (lipohypertrophy) when injecting insulin improves blood sugar control.
- It uses ultrasound to find both visible and hidden fatty areas under the skin.
- Participants must have Type 1 or Type 2 diabetes and be on insulin for at least two years.
- The study has two phases: locating lumps with ultrasound, then testing injection sites for blood sugar impact.
- Learning outcomes could help improve insulin injection techniques for better diabetes management.
- Participation is voluntary, and you can withdraw at any time without affecting your medical care.
Who may be eligible?
To be able to take part in this study, you need to have been diagnosed with either Type 1 or Type 2 diabetes. You also need to be injecting insulin daily or using an insulin pump for at least two years. The study is open to adults aged 19 years and older, up to 80 years old, and is open to everyone, regardless of gender.
There are some reasons why you might not be able to join the study. For example, if you are currently taking certain types of medication for diabetes called glucagon-like peptide medications, or if you are on steroid medicines like prednisone, you wouldn't be able to participate. Also, if you have other skin conditions in the areas where you inject insulin that aren't related to lipohypertrophy, or if you aren't fluent in English and don't have a translator with you, you wouldn't be able to join.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Do I have Type 1 or Type 2 diabetes?
- Do I inject insulin daily or use an insulin pump, and have I done so for at least 2 years?
- Am I aged between 19 and 80 years old?
- Am I NOT taking glucagon-like peptide medications or steroid medications (like prednisone)?
- Do I NOT have other skin conditions in my injection areas that are not lipohypertrophy?
- Am I able to understand and speak English (or have a translator with me for all appointments)?
What does participation involve?
If you decide to participate in this study, it involves two phases. In the first phase, we will use a portable ultrasound machine to scan the areas where you typically inject insulin. This is to see if there are any fatty lumps (lipohypertrophy), even small ones you can't feel. This phase will involve one or more visits for the scans. If you are identified as having hidden lipohypertrophy in Phase 1, you may be invited to take part in Phase 2.
Phase 2 involves closer monitoring of your blood sugar. You will be asked to check your glucose levels regularly. This part of the study is designed as a 'crossover' study, meaning you will compare injecting insulin into areas with lipohypertrophy versus areas without, under careful guidance. The total duration of your participation will depend on which phase you are in and how long the blood sugar monitoring lasts in Phase 2. All your regular diabetes medications will continue as usual, but specific instructions may be given about your injection sites during Phase 2. More details on the number of visits and exact assessments will be provided if you are eligible and interested.
Potential risks and benefits
Locations (1)
- Vancouver General Hospital Diabetes CentreVerified postcodeVancouver, Canada· Recruiting
Common questions
What is lipohypertrophy?
It's a swollen, fatty area under the skin, often caused by repeated insulin injections in the same spot. It can feel like a lump or bump.
Why is this study important for people with diabetes?
It aims to find out if avoiding these fatty lumps when injecting insulin can help improve blood sugar control, potentially making your insulin work better.
Will I have to stop my current insulin treatment?
No, you will continue your usual insulin treatment. The study is looking at how best to inject it.
What does an ultrasound scan involve?
It's a quick, painless scan using a small device held against your skin to create images of the tissue underneath, similar to scans used during pregnancy.
How long will I be in the study if I participate?
The total time will depend on which phase you're in, but full details will be given by the study team before you decide to join.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.